Our Research Saves Lives: MRA Grants Over $100 Million in Ten Years
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 25 April 2018 In News, Science
Through powerful research, the Melanoma Research Alliance (MRA) is quickly delivering results and saving lives. In ten years, the Melanoma Research Alliance has become the largest, non-profit funder of melanoma research worldwide. In fact, with Tuesday's announcement of 28 new grant awards – MRA has now funded $100 million in the areas of prevention, diagnosis, and treatment!
Your Opportunity to Help Advance Melanoma Research
Beyond protecting yourself through sun-safety and skin-checks – one of the best ways you can observe Melanoma Awareness Month is by raising funds to support melanoma research!
Embrace Your Skin and Don't Be Anything that You Aren't
This freckled red head was never meant to be tan, but it didn’t stop her from trying. Stefani Schuetz just wanted that ‘perfect glow’ that she hoped would help her fit in after moving to Florida. She was training for a triathalon – a race requiring swimming, cycling, and running – with her sister when everything changed. Her sister thought she saw a bug on the back of her leg – but this bug turned out to be much worse. Instead of a bug, Stefani found a suspect mole that she’d never noticed before. She knew she had to get it checked out, but money was tight for this single Mom; it took her four months to make it to the dermatologist for a biopsy.
Libby Kistler: “I’m Still Here”
Statistically, Libby Kistler shouldn’t be here. She was diagnosed with Stage IIIB melanoma in 2005, before treatment for late-stage melanoma was transformed by immuno- and targeted therapies in 2011.
Immunotherapy & Chemotherapy – Two Different Approaches
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 21 March 2018 In Science, Treatment
We’ve all seen the movie where the heroic cancer patient bravely moves through treatment as she deals with nausea, hair loss, and other side effects. For many cancer patients this picture is true, however imprecise. Hollywood has conditioned us to equate cancer treatment with chemotherapy. Twenty years ago this narrative was more or less accurate, but in a world where immunotherapies and other new treatments are increasingly being used, this narrative isn’t keeping up with today’s reality. For some people with melanoma, this stuck-in-the-past narrative may even be deadly.
What’s Next in Melanoma Treatment?
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 20 March 2018 In Science, Treatment
Dr. Douglas Johnson, MRA Young Investigator awardee and Assistant Professor of Medicine and Melanoma Clinical Director at the Vanderbilt-Ingram Cancer Center, outlines three broad areas of current and future melanoma research.
Leveraged Finance Community Comes Together to Fight Melanoma
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 19 March 2018 In Events
On May 23, 2018 more than one thousand professionals from the leveraged finance and finance community at-large will come together in the fight against melanoma for the seventh annual Leveraged Finance Fights Melanoma (LFFM) benefit and cocktail party. The event, held each year in the Rockefeller Center’s summer garden, has raised over $8.6 million to advance the Melanoma Research Alliance’s global research programs.
Melanoma is Determined, So is Eric
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 20 February 2018 In Melanoma Stories
After 7 clinical trials, 8 surgeries, and more infusions than he can count --- Eric Martin is still here, seven years after being diagnosed with melanoma. He has had ups and downs and has tried practically every FDA-approved therapy for melanoma – but the crux of this story, which all readers need to understand, is that Eric’s fight isn’t yet finished. That’s because unlike many of the stories featured by MRA – Eric is still searching for his silver bullet and the elusive letters N.E.D. (no evidence of disease). He’s got big plans and melanoma isn’t going to get in the way. In short, Eric is a melanoma warrior.
Finding the Magic Formula
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 7 February 2018 In Science, Treatment
Modern immunotherapy, with melanoma as its poster child, is changing the way we treat cancer - for good. But, so far at least, it isn't helping everyone. Many scientists believe that there isn't a single silver bullet to unleash the awesome power of our immune systems - and instead - that the future of oncology is finding just the right combination of therapies that push and pull from different directions to multiply and enhance each other's effectiveness.
"I Thought I Knew Myself, but I Missed It."
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 7 February 2018 In Melanoma Stories, Prevention
Jim can’t say enough about his dermatologist who was able to detect his melanoma early enough so that more invasive treatment wasn’t necessary. “I see myself every day. I thought I knew myself, but I missed it. I see her twice a year, and those visits are quick, but she didn’t miss it. She was all over it.” The vigilance of his dermatologist may have saved Jim’s life.